StockSelector.com
  Research, Select, & Monitor Monday, May 22, 2017 7:18:49 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
United Therapeutics Corp.$122.57$.93.76%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

United Therapeutics Corp. has an overall rank of 474 out of 6845 stocks based on 13 positive rankings and 10 negative rankings.

Positive Rankings
Highest ROA
United Therapeutics rank is 61
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, United Therapeutics is ranked 85.
Top Industry Values
United Therapeutics rank is 95
Highest Cash Growth
United Therapeutics rank is 130
Highest Net Margin
United Therapeutics rank is 155
Highest ROE
United Therapeutics rank is 205
Historic EPS Growth
United Therapeutics rank is 222
Target Prices
The average analysts' target price is $162.50 for United Therapeutics using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, United Therapeutics is ranked 304.
Up Estimate Revision
During the past month, the consensus earnings estimate for the current year and next year have increased by a combined 2.07%. Among companies that have had their estimates raised within the past month, United Therapeutics is ranked 516.
Debt-to-Equity
United Therapeutics rank is 558
Up Ratings Revision
During the past month, the average analyst's rating or recommendation has increased. Among companies that have been upgraded within the past month, United Therapeutics is ranked 668.
Historic Revenue Growth
United Therapeutics rank is 778
Up EPS Surprise
United Therapeutics beat the consensus earnings estimate when it last reported quarterly earnings.
Negative Rankings
Negative EPS Growth
United Therapeutics rank is 60
Negative Revenue Estimate
United Therapeutics rank is 168
Missed Whisper
According to EarningsWhispers.com, United Therapeutics missed the Earnings Whisper number when it last reported earnings. Statistics show that companies that have missed the Earnings Whisper number underperform the market in the short-term.
High Put/Call
United Therapeutics has a high Put/Call ratio of 0.90 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, United Therapeutics is ranked 344.
High vPut/Call
United Therapeutics has a high Put/Call ratio of 1.53 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, United Therapeutics is ranked 528.
90 Day Loss
United Therapeutics rank is 698
Down EPS Surprise
United Therapeutics missed the consensus earnings estimate when it last reported quarterly earnings.
Price-to-Book
United Therapeutics rank is 1681
Price-to-Sales
United Therapeutics rank is 1760
10 Day Loss
United Therapeutics rank is 2047







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2017 StockSelector.com. All rights reserved.